Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.9B | 4.7B | 4.8B | 4.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 512M | 461M | 834M | 453M |
| Other operating expenses | 291M | 273M | 305M | 322M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.2B | 2.2B | 2.3B | 2.2B |
| Tax provision | 609M | 580M | 614M | 590M |
| Net income | 1.6B | 1.6B | 1.7B | 1.6B |
| Basic EPS | 5.0 | 5.0 | 5.2 | 4.9 |
| Diluted EPS | 5.0 | 5.0 | 5.2 | 4.9 |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |